The Safety and Efficacy of Early-stage Bi-weekly Alendronate to Improve Bone Mineral Density and Bone Turnover in Chinese Post-menopausal Women at Risk of Osteoporosis

By You L   Sheng Z-Y   Chen J-Y   Pan L   Chen L  

The Journal of International Medical Research, Vol. 39, Iss. 1, 2011-01 ,pp. : 302-310

Field House Publishing

Access to resources Recommend Favorite

Three-year Experience with Alendronate Treatment in Postmenopausal Osteoporotic Japanese Women with or without Renal Dysfunction: A Retrospective Study

By Iwamoto Jun  

Drugs & Aging, Vol. 29, Iss. 2, 2012-02 ,pp. : 133-142

Adis International

Access to resources Recommend Favorite

Biological Effects of Supplementation with Vitamin D and Calcium in Postmenopausal Women with Low Bone Mass Receiving Alendronate

By Brazier M.  

Clinical Drug Investigation, Vol. 22, Iss. 12, 2002-01 ,pp. : 849-857

Adis International

Access to resources Recommend Favorite

Anastrozole use does not appear to change bone mineral density (BMD) or bone turnover markers in postmenopausal Japanese women with breast cancer

By  

Reactions Weekly, Vol. 1, Iss. 1122, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Calcium, vitamin D supplements with or without alendronate and supragingival calculus formation in osteoporotic women: a preliminary study

By Buduneli Nurcan   Saygan Buket Han   Karaduman Ural   Saraç Fulden   Karaduman Musa   Ayçelik Necmettin  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 12, 2008-08 ,pp. : 2015-2020

Informa Healthcare

Access to resources Recommend Favorite